Skip to main navigation Skip to search Skip to main content

Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)

    • Healthpoint Hospital

    Project: Clinical Trial

    Project Details

    Layman's description

    This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90).

    Key findings

    - Before induction of general anesthesia, all patients will receive interscalene block using 15ml of ropivacaine which concentration will be based on the response of the previous patient.
    - Based on biased-coin design up-down sequential method: if patient has pain free recovery, a successful block, the next patient will be randomized to receive either the same ropivacaine concentration or a concentration 0.01% w/v less. However, if he has an unsuccessful block, the next patient will receive a concentration 0.01% w/v higher.
    - Patients with pain free recovery will be considered to have positive response.
    - Patients' responses will be analyzed to calculate the MEAC90.
    StatusFinished
    Effective start/end date1/05/2130/09/21

    Collaborative partners

    Keywords

    • Postoperative Complications
    • Pathologic Processes
    • Pain
    • Neurologic Manifestations
    • Postoperative Pain
    • Local Anesthetics
    • Anesthetics
    • Central Nervous System Depressants
    • Physiological Effects of Drugs
    • Sensory System Agents
    • Peripheral Nervous System Agents
    • Ropivacaine

    Fingerprint

    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.